Sharp Therapeutics Corp. (TSXV:SHRX)
Canada
· Delayed Price · Currency is CAD 1.850
0.00 (0.00%)
At close: Apr 30, 2025
Sharp Therapeutics Statistics
Total Valuation
TSXV:SHRX has a market cap or net worth of CAD 55.39 million. The enterprise value is 52.26 million.
| Market Cap | 55.39M |
| Enterprise Value | 52.26M |
Important Dates
The next estimated earnings date is Thursday, August 21, 2025.
| Earnings Date | Aug 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:SHRX has 29.94 million shares outstanding. The number of shares has increased by 11,406.81% in one year.
| Current Share Class | 29.94M |
| Shares Outstanding | 29.94M |
| Shares Change (YoY) | +11,406.81% |
| Shares Change (QoQ) | +58.04% |
| Owned by Insiders (%) | 3.42% |
| Owned by Institutions (%) | 0.70% |
| Float | 16.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -58.14 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.88 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.28 |
Financial Position
The company has a current ratio of 0.84
| Current Ratio | 0.84 |
| Quick Ratio | 0.79 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.30 |
| Interest Coverage | -19.14 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -231.08% |
| Return on Capital Employed (ROCE) | -539.69% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 46.91 |
| Average Volume (20 Days) | 2,837 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -4.68M |
| Pretax Income | -7.60M |
| Net Income | -7.60M |
| EBITDA | -4.66M |
| EBIT | -4.68M |
| Earnings Per Share (EPS) | -0.47 |
Balance Sheet
The company has 2.90 million in cash and 1.88 million in debt, giving a net cash position of 1.02 million or 0.03 per share.
| Cash & Cash Equivalents | 2.90M |
| Total Debt | 1.88M |
| Net Cash | 1.02M |
| Net Cash Per Share | 0.03 |
| Equity (Book Value) | -952,545 |
| Book Value Per Share | -0.03 |
| Working Capital | -582,230 |
Cash Flow
In the last 12 months, operating cash flow was -6.34 million and capital expenditures 23,864, giving a free cash flow of -6.31 million.
| Operating Cash Flow | -6.34M |
| Capital Expenditures | 23,864 |
| Free Cash Flow | -6.31M |
| FCF Per Share | -0.21 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSXV:SHRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11,406.81% |
| Shareholder Yield | n/a |
| Earnings Yield | -13.72% |
| FCF Yield | -11.40% |
Stock Splits
The last stock split was on January 27, 2025. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jan 27, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |